225AC-PSMA-XT
N/A
Report date: 2026/03/26 20:00:17
NME
Base Information
Drug Name225AC-PSMA-XT
Drug Alias Name
Classification +[4]
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesCancer Hospital of Shandong First Medical University
China Registration ClassN/A
Develop Information
Active CompaniesCancer Hospital of Shandong First Medical University
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A